Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67 percent Y-o-Y - Moneycontrol

KREBSBIO   109.74  5.60  5.38%   
Under 54% of Krebs Biochemicals' traders are presently thinking to get in. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that some investors are interested at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
  
Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67 percent Y-o-Y Moneycontrol

Read at news.google.com
Google News at Macroaxis
  

Krebs Biochemicals Fundamental Analysis

We analyze Krebs Biochemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Krebs Biochemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Krebs Biochemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

Krebs Biochemicals is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Krebs Biochemicals and Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Krebs Biochemicals stock to make a market-neutral strategy. Peer analysis of Krebs Biochemicals could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics with similar companies.

Complementary Tools for Krebs Stock analysis

When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets